Cibc World Market Inc. Makes New $14.61 Million Investment in HCA Healthcare, Inc. $HCA

Key Points

• CIBC World Markets acquired 37,460 shares of HCA Healthcare in the second quarter, worth approximately $14.61 million. Institutional investors and hedge funds collectively own 62.73% of the company.
• HCA Healthcare reported quarterly revenue of $20.23 billion, up 8.7% year over year, and adjusted earnings of $7.59 per share, narrowly beating analyst expectations.
• The company declared a quarterly dividend of $0.78 per share, or $3.12 annually, representing a 0.7% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $462.64.

Cibc World Market Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 37,460 shares of the company's stock, valued at approximately $14,605,000.

Several other large investors have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at $5,069,974,000. Norges Bank acquired a new stake in HCA Healthcare in the fourth quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare in the fourth quarter worth about $374,037,000. Viking Global Investors LP increased its position in HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock worth $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. boosted its position in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company's stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.0%

Shares of NYSE:HCA opened at $429.19 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The stock has a market cap of $92.92 billion, a PE ratio of 14.37, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The stock's fifty day simple moving average is $397.94 and its two-hundred day simple moving average is $443.28.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the company posted $6.84 earnings per share. The firm's revenue for the quarter was up 8.7% on a year-over-year basis. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on HCA shares. Barclays dropped their price target on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research note on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a research note on Monday, July 27th. Morgan Stanley decreased their price target on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a report on Monday, July 27th. Finally, Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research note on Tuesday, July 14th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source